| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.41 | 0.02 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |